Beta-Hydroxybutyrate Feasibility Treating IBD
Abroad (travel likely)RecruitingPHASE1, PHASE2
Conditions
Crohn's Disease · Inflammatory Bowel Diseases
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Texas at Austin, Austin, Texas, United States
Contact: Study coordinator (Michelle Stickler, Associate Vice President, DEd) · m.stickler@austin.utexas.edu · 512-475-6323Contact: Study coordinator (Thomas Street, Executive Director) · thomas.street@austin.utexas.edu · 512 495 5142
Study leads
Linda A. Feagins, Associate Professor, MD
Principal Investigator
University of Texas at Austin